This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Epstein, S. E. Articles by Rosing, D. R. Search for Related Content PubMed PubMed Citation Articles by Epstein, S. E. Articles by Rosing, D. R.

Circulation, Vol 64, 437-441, Copyright © 1981 by American Heart Association

ARTICLES

Verapamil: its potential for causing serious complications in patients with hypertrophic cardiomyopathy

SE Epstein and DR Rosing

Verapamil is extremely effective in the treatment of patients with hypertrophic cardiomyopathy. However, the basic physiologic actions of the drug may lead to serious adverse effects. An appreciation of this and an understanding of when these adverse effects are most likely to occur will minimize the potential of verapamil to cause serious complications in patients with hypertrophic cardiomyopathy.

This article has been cited by other articles:

				T. E. Sirak and M. V. Sherrid Oral Disopyramide for the Acute Treatment of Severe Outflow Obstruction in Hypertrophic Cardiomyopathy in the ICU Setting Chest, May 1, 2008; 133(5): 1243 - 1246. [Abstract] [Full Text] [PDF]

				M. A. Fifer and G. J. Vlahakes Management of Symptoms in Hypertrophic Cardiomyopathy Circulation, January 22, 2008; 117(3): 429 - 439. [Full Text] [PDF]

				M. V. Sherrid, I. Barac, W. J. McKenna, P. M. Elliott, S. Dickie, L. Chojnowska, S. Casey, and B. J. Maron Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy J. Am. Coll. Cardiol., April 19, 2005; 45(8): 1251 - 1258. [Abstract] [Full Text] [PDF]

				R. A. Nishimura and D. R. Holmes Jr. Hypertrophic Obstructive Cardiomyopathy N. Engl. J. Med., March 25, 2004; 350(13): 1320 - 1327. [Full Text] [PDF]

				E. Grunig, A. Benz, D. Mereles, K. Unnebrink, H. Kucherer, M. Haass, W. Kubler, and H. A. Katus Prognostic value of serial cardiac assessment and familial screening in patients with dilated cardiomyopathy Eur J Heart Fail, January 1, 2003; 5(1): 55 - 62. [Abstract] [Full Text] [PDF]

				B. J. Maron Hypertrophic Cardiomyopathy: A Systematic Review JAMA, March 13, 2002; 287(10): 1308 - 1320. [Abstract] [Full Text] [PDF]

				K. A. Crispell, A. Wray, H. Ni, D. J. Nauman, and R. E. Hershberger Clinical profiles of four large pedigrees with familial dilated cardiomyopathy: Preliminary recommendations for clinical practice J. Am. Coll. Cardiol., September 1, 1999; 34(3): 837 - 847. [Abstract] [Full Text] [PDF]

				M. H. Park, D. M. Gilligan, N. L. Bernardo, and O. Topaz Symptomatic Hypertrophic Obstructive Cardiomyopathy: The Role of Dual-Chamber Pacing Angiology, February 1, 1999; 50(2): 87 - 94. [Abstract] [PDF]

				Y. Sato, K. Kataoka, A. Matsumori, S. Sasayama, T. Yamada, H. Ito, and Y. Takatsu Measuring serum aminoterminal type III procollagen peptide, 7S domain of type IV collagen, and cardiac troponin T in patients with idiopathic dilated cardiomyopathy and secondary cardiomyopathy Heart, November 1, 1997; 78(5): 505 - 508. [Abstract] [Full Text] [PDF]

				P. Spirito, C. E. Seidman, W. J. McKenna, and B. J. Maron The Management of Hypertrophic Cardiomyopathy N. Engl. J. Med., March 13, 1997; 336(11): 775 - 785. [Full Text] [PDF]

				E. D. Wigle, H. Rakowski, B. P. Kimball, and W. G. Williams Hypertrophic Cardiomyopathy : Clinical Spectrum and Treatment Circulation, October 1, 1995; 92(7): 1680 - 1692. [Full Text]

				C. Cho, A. W. Pruitt, J. J. Corrigan Jr, H. D. Allen, R. Hong, and C. T. Kisker Therapeutic Uses of Calcium Channel-Blocking Drugs in the Young Arch Pediatr Adolesc Med, April 1, 1986; 140(4): 360 - 366. [Abstract] [PDF]

				M. H. Hwang, J. Danoviz, I. Pacold, N. Rad, H. S. Loeb, and R. M. Gunnar Double-blind Crossover Randomized Trial of Intravenously Administered Verapamil: Its Use for Atrial Fibrillation and Flutter Following Open Heart Surgery Arch Intern Med, March 1, 1984; 144(3): 491 - 494. [Abstract] [PDF]

				D. L. Morris and N. Goldschlager Calcium Infusion for Reversal of Adverse Effects of Intravenous Verapamil JAMA, June 17, 1983; 249(23): 3212 - 3213. [Abstract] [PDF]

				Cardiovascular Diseases: An Annotated Bibliography of Recent Literature: References to Journal Articles and Other Papers Ann Intern Med, May 1, 1983; 98(5_Part_1): 679 - 685. [Abstract] [PDF]

				D. R. ROSING and S. E. EPSTEIN Verapamil in the Treatment of Hypertrophic Cardiomyopathy Ann Intern Med, May 1, 1982; 96(5): 670 - 672. [Abstract] [PDF]